Anti-fibrinolytic agents in bleeding disorders – A clinical perspective
y
21 abr 2018
Acerca de este artículo
Categoría del artículo: Commentary
Publicado en línea: 21 abr 2018
Páginas: 80 - 83
DOI: https://doi.org/10.17225/jhp00089
Palabras clave
© 2018
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Badle, Saket
The Royal London Hospital Haemophilia Centre, Barts and The London School of Medicine and Dentistry, QMUL,London, UK
Hart, Daniel P.
The Royal London Hospital Haemophilia Centre, Barts and The London School of Medicine and Dentistry, QMUL,London, UK